Mexiletine

Mexiletine
Mexiletine
Systematic (IUPAC) name
(RS)-1-(2,6-dimethylphenoxy)propan-2-amine
OR
2-(2-aminopropoxy)-1,3-dimethylbenzene
Clinical data
AHFS/Drugs.com monograph
MedlinePlus a607064
Pregnancy cat. B1(AU) C(US)
Legal status POM (UK)
Routes Oral, IV
Pharmacokinetic data
Bioavailability 90%
Protein binding 50-60%
Metabolism Hepatic (CYP2D6 and 1A2- mediated)
Half-life 10-12 hours
Excretion Renal (10%)
Identifiers
CAS number 31828-71-4 YesY
ATC code C01BB02
PubChem CID 4178
IUPHAR ligand 2629
DrugBank APRD00242
ChemSpider 4034 YesY
UNII 1U511HHV4Z YesY
KEGG D08215 YesY
ChEBI CHEBI:6916 N
ChEMBL CHEMBL558 YesY
Chemical data
Formula C11H17NO 
Mol. mass 179.259 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Mexiletine (INN, sold under the trade name Mexitil) belongs to the Class IB anti-arrhythmic group of medicines. It is used to treat arrhythmias within the heart, or seriously irregular heartbeats. It slows conduction in the heart and makes the heart tissue less sensitive. Dizziness, heartburn, nausea, nervousness, trembling, unsteadiness are common side effects. It is available in injection and capsule form.

Class IB antiarrhythmics decrease action potential duration by shortening the repolarization phase. This is achieved by blocking sodium channels.[1]

Mexiletine may also be of use in patients experiencing refractory pain[2] and is also effective for treating muscle stiffness resulting from myotonia congenita (Thomsen disease) or myotonic dystrophy (Steinert's disease).

References

  1. ^ Mexiletine, RxList.com
  2. ^ Sweetman S (ed.) (2002). Martindale: The complete drug reference (33rd ed. ed.). London: Pharmaceutical Press. ISBN 0-85369-499-0. 

Further reading

  • Peck T; Hill S, Williams M (eds.) (2004). Pharmacology for Anaesthesia and Intensive Care (2nd ed. ed.). Cambridge University Press. ISBN 0-521-68794-2. 

External links